<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: COVID-19: Developing Drugs and Biological Products for Treatment or Prevention; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: COVID-19: Developing Drugs and Biological Products for Treatment or Prevention; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2023-11-24 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "COVID-19: Developing Drugs and Biological Products for Treatment or Prevention." The purpose of this guidance is to assist sponsors in the clinical development of drugs and biological products for the treatment or prevention of COVID-19. This guidance describes FDA's current recommendations for phase 2 and phase 3 trials with a focus on trial population, trial design, effica...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-25952</p>
    <p><strong>Publication Date:</strong> 2023-11-24</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/11/24/2023-25952/covid-19-developing-drugs-and-biological-products-for-treatment-or-prevention-guidance-for-industry">https://www.federalregister.gov/documents/2023/11/24/2023-25952/covid-19-developing-drugs-and-biological-products-for-treatment-or-prevention-guidance-for-industry</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-25952</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
